In bacterial infections, particularly sepsis, IL-38 reduces the release of pro-inflammatory cytokines (IL-6, TNF-α, IL-17) and promotes regulatory T cell responses, thereby mitigating tissue injury and improving survival in experimental models [28]. The gene discussed is IL17A; the disease is Sepsis.